GPC3 and neoplasm: It was found that the antibody-immunotoxin complex was specifically cytotoxic to GPC3-positive tumor cells, while the 32A9-CAR-T cells destroyed the tumor cells in vitro and promoted regression of HCC xenograft tumors in vivo (65).